Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11957662 Treatments with nirogacestat

Patent 11957662 was granted and assigned to SpringWorks Therapeutics on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SpringWorks Therapeutics

Current Assignee

SpringWorks Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119576620

Patent Inventor Names

Kristin Patterson0

Allison Lim0

Shinta Cheng0

Todd Webster Shearer0

Rex Williams0

Date of Patent

April 16, 2024

Patent Application Number

184913790

Date Filed

October 20, 2023

Patent Citations

‌

US Patent 10590087 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

‌

US Patent 7795447 Imidazole compounds for the treatment of neurodegenerative disorders

‌

US Patent 11872211 Treatments with nirogacestat

Patent Citations Received

‌

US Patent 12011435 Treatments with nirogacestat

Patent Primary Examiner

‌

Brian J Davis

Patent abstract

The present disclosure relates to improved methods of treatment with nirogacestat.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11957662 Treatments with nirogacestat

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API